Immunology
Assay Detects Minimal Residual Disease in Blood Based Cancers
A clinical assay measures minimal residual disease in a range of blood-based cancers that will help doctors more effectively determine effectiveness of treatments, monitor patient remission status, and personalize future treatments. More...18 Dec 2012
Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
In Other News
Improved Detection of Polyomavirus in Merkel Cell Carcinoma
Test Helps Monitor Patients with Epithelial Ovarian Cancer
Plants Provide Diagnostic Reagent for West Nile Virus
Gene Signature Identified for Juvenile Arthritis
Ultrasensitive Sensor Detects Early Stages of Diseases
Nanofibrillar Cellulose Film Platform to Support Medical Testing
Whole Blood Controls Monitor Immunosuppressant Drug Test Precision
Serological Assays Assessed for Q Fever
A Single-Molecule Digital Immunoassay Identifies HIV in Blood
Nanotechnology Detects Antibodies in Blood
Oscillating Microscopic Beads Used for Biochip
ELISA Reader Features Modern Light Source, Small Footprint
Oral Bacteria Associated with Pancreatic Cancer Risk
Premature Birth Predicted by Immunoassay
Blood Test Tracks Huntington's Disease Progression
Diagnostic Tests Recognize Specific Disease Proteins
Assay Released for Free Protein S Antigen Testing
Assay Measures Low Levels of Testosterone
Urine Test Predicts Risk of Bone Fracture
Polyomavirus May Have Role in Prostate Cancer
Blood Test Predicts Low Birth Weight
Automated Chemiluminescent Assays Evaluated for Heparin-Induced Antibodies
Peptides for Immunoenzymatic Assays Immobilized on Microplates
The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.